Post-exposure doxycycline to prevent sexually transmitted infection in women
|
Reviewed by Dat Tien Nguyen, B.A, ScM.
Translated by Nhi Phuong Quynh Le, B.A |
Posted on February 14th, 2024
|
Women bear a disproportionate burden of severe consequences from sexually transmitted infections compared to men or transgender women. With the rising incidence of chlamydia, gonorrhea, and syphilis, there has been a renewed focus on refining preventive measures. Consequently, a study was undertaken to explore the potential benefits of post-exposure doxycycline.
The research involved 449 women aged between 18 and 30 years who were undergoing pre-exposure prophylaxis for HIV. Over 30% of participants had engaged in sexual activity with a new partner in the past 3 months, and condom usage stood at approximately 31%. Half of the study cohort was directed to take 200 mg of doxycycline within 72 hours following condomless sexual intercourse. Nucleic acid amplification testing for sexually transmitted infections was conducted every 4 months. After a 12-month period, the study findings indicated that post-exposure prophylactic doxycycline did not significantly reduce the risk of sexually transmitted infections. The researchers also performed detection of the tet(M) resistance gene, revealing a 100% resistance rate in Neisseria gonorrhoeae, hypothesized to be a contributing factor to the limited effectiveness of doxycycline.
The research involved 449 women aged between 18 and 30 years who were undergoing pre-exposure prophylaxis for HIV. Over 30% of participants had engaged in sexual activity with a new partner in the past 3 months, and condom usage stood at approximately 31%. Half of the study cohort was directed to take 200 mg of doxycycline within 72 hours following condomless sexual intercourse. Nucleic acid amplification testing for sexually transmitted infections was conducted every 4 months. After a 12-month period, the study findings indicated that post-exposure prophylactic doxycycline did not significantly reduce the risk of sexually transmitted infections. The researchers also performed detection of the tet(M) resistance gene, revealing a 100% resistance rate in Neisseria gonorrhoeae, hypothesized to be a contributing factor to the limited effectiveness of doxycycline.